首页> 美国卫生研究院文献>Global Journal of Health Science >Effects of Letrozole-HMG and Clomiphene-HMG on Incidence of Luteinized Unruptured Follicle Syndrome in Infertile Women Undergoing Induction Ovulation and Intrauterine Insemination: A Randomised Trial
【2h】

Effects of Letrozole-HMG and Clomiphene-HMG on Incidence of Luteinized Unruptured Follicle Syndrome in Infertile Women Undergoing Induction Ovulation and Intrauterine Insemination: A Randomised Trial

机译:来曲唑-HMG和克罗米芬-HMG对接受诱导排卵和宫内授精的不育女性黄体化未破裂卵泡综合征发生率的随机试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:Luteinized unruptured follicle (LUF) syndrome is considered a cause of ovulation failure and a subtle cause of infertility. Preovulatory injection of human chorionic gonadotropin (HCG) prevents or treats LUF syndrome, but it has also occurred after the induction of ovulation with clomiphene/HMG and HCG. This study was designed for evaluation and comparison of LUF incidence in eligible infertile women undergoing two stimulation protocols (clomiphene + HMG and letrozole + HMG) in addition to intrauterine insemination (IUI). Some related factors were compared between LUF and non-LUF cycles as secondary outcomes.
机译:背景:黄体化未破裂卵泡(LUF)综合征被认为是排卵失败的原因,也是不孕的细微原因。排卵前注射人绒毛膜促性腺激素(HCG)可以预防或治疗LUF综合征,但在用克罗米芬/ HMG和HCG诱导排卵后也是如此。本研究旨在评估和比较接受除子宫内授精(IUI)以外的两种刺激方案(克罗米芬+ HMG和来曲唑+ HMG)的合格不育妇女的LUF发生率。比较了LUF和非LUF周期中的一些相关因素作为次要结果。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号